Ravi Kr. Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ravi Kr. Gupta has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Deshraj Deepak Kapoor
Department of Environmental Microbiology, Babasaheb Bhimrao Ambedkar University, Lucknow, India
3 shared publications Shilpi Yadav
Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Uttar Pradesh, Lucknow, India
3 shared publicationsAbhishek Kumar
Department of Environmental Microbiology, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Lucknow-226025 (Uttar Pradesh), India
2 shared publications- Abhishek Kumar2 shared publications
Ruchi Sankhwar
Department of Environmental Microbiology, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Lucknow-226025 (Uttar Pradesh), India
2 shared publications- Ruchi Sankhwar2 shared publications
Latest Publications
- 24 September 2025
- Published by Springer Nature in Journal of Polymer Research
- Vol. 32 (10) , 1-30
Transition towards renewable and biodegradable polymers: a comprehensive review
- 24 September 2025
- Published by Springer Nature in Journal of Polymer Research
- Vol. 32 (10) , 1-30
Transition towards renewable and biodegradable polymers: a comprehensive review
- 2 May 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 11696-11711
Leaf miRNAs of Withania somnifera Negatively Regulate the Aging-Associated Genes in C. elegans
Aging is a physiological process that culminates in cellular senescence, a phenomenon that has significant implications for health and longevity. Plant-based therapeutics, particularly the root of Withania somnifera, have been reported to delay the onset and progression of aging and its associated disorders, including Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders. However, the role of leaf-derived microRNAs (miRNAs) from W. somnifera in the molecular regulation of genes involved in aging remains poorly understood. Caenorhabditis elegans serves as an indispensable model organism for studying aging-associated gene regulation due to its short lifespan, conserved human orthologs, and ease of laboratory cultivation. In this study, we explored the regulatory interactions between miRNAs derived from the leaf tissues of W. somnifera and aging-associated genes, utilizing C. elegans as a model organism. We employed bioinformatics to identify miRNAs that interact with aging-associated genes in C. elegans and found that three specific miRNAs in the leaf tissue of W. somnifera interacted with these genes. To assess the physiological effects of these miRNAs on C. elegans, we conducted biochemical assays, including lifespan, chemotaxis, and stress resistance assays. Additionally, we investigated the differential gene expression of the interacting genes in the presence and absence of W. somnifera leaf miRNA treatment using real-time PCR. The results indicated that the expression levels of the age-1 and sel-12 genes were significantly downregulated, while the apl-1 gene was upregulated following treatment with leaf miRNAs in C. elegans. These findings suggest that miRNAs derived from W. somnifera leaves may play a crucial role in regulating aging-associated gene expression. This is the first study, to our knowledge, that identifies the miRNAs of W. somnifera leaf involved in aging-associated gene regulation, thereby paving the way for future research into the therapeutic potential of plant-derived miRNAs in combating age-related disorders.
- 2 May 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 11696-11711
Leaf miRNAs of Withania somnifera Negatively Regulate the Aging-Associated Genes in C. elegans
Aging is a physiological process that culminates in cellular senescence, a phenomenon that has significant implications for health and longevity. Plant-based therapeutics, particularly the root of Withania somnifera, have been reported to delay the onset and progression of aging and its associated disorders, including Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders. However, the role of leaf-derived microRNAs (miRNAs) from W. somnifera in the molecular regulation of genes involved in aging remains poorly understood. Caenorhabditis elegans serves as an indispensable model organism for studying aging-associated gene regulation due to its short lifespan, conserved human orthologs, and ease of laboratory cultivation. In this study, we explored the regulatory interactions between miRNAs derived from the leaf tissues of W. somnifera and aging-associated genes, utilizing C. elegans as a model organism. We employed bioinformatics to identify miRNAs that interact with aging-associated genes in C. elegans and found that three specific miRNAs in the leaf tissue of W. somnifera interacted with these genes. To assess the physiological effects of these miRNAs on C. elegans, we conducted biochemical assays, including lifespan, chemotaxis, and stress resistance assays. Additionally, we investigated the differential gene expression of the interacting genes in the presence and absence of W. somnifera leaf miRNA treatment using real-time PCR. The results indicated that the expression levels of the age-1 and sel-12 genes were significantly downregulated, while the apl-1 gene was upregulated following treatment with leaf miRNAs in C. elegans. These findings suggest that miRNAs derived from W. somnifera leaves may play a crucial role in regulating aging-associated gene expression. This is the first study, to our knowledge, that identifies the miRNAs of W. somnifera leaf involved in aging-associated gene regulation, thereby paving the way for future research into the therapeutic potential of plant-derived miRNAs in combating age-related disorders.
- Open Access
- 19 September 2024
- Published by ANSF Publications in Journal of Applied and Natural Science
- Vol. 16 (3) , 987-997
Comparative metagenomic analysis of bacterial diversity in three distantly related soils in India
Soil microbial diversity is a vital factor for the progression of vegetation and biogeochemical cycles in an ecosystem. It is affected by the chemical composition, soil microenvironment and anthropogenic activities. The present study investigated the effect of environmental conditions and anthropogenic activities on the bacterial diversity of three distantly related soils in India. The multiple soil samples were collected from Hospital waste sites (BTC2) with extensive anthropogenic activity, Himalayan forest soil (RM1) with low anthropogenic activity and Tso Kar Lake sediment soil samples with negligible anthropogenic activity with environmental factors such as soil pH, temperature and altitude on the bacterial diversity. The soil samples were analyzed for physico-chemical properties that suggest significant variations in pH, electrical conductivity (EC), total dissolved solids (TDS), temperature and altitude. The SEM-EDS (Scanning electron microscopy with energy-dispersive X-ray spectroscopy) analysis revealed the elemental composition of the soil samples. The bacterial diversity of three different soil samples was studied using 16S rRNA sequencing-based metagenomic analysis. The results suggested that the bacterial diversity in Hospital waste site soil samples was higher than in the other two soil samples based on chao1 (richness and evenness) analysis. The Phyla Firmicutes were more abundant in Hospital waste site soil, and Himalayan forest soil showed a higher abundance of phylum Proteobacteria (28.86%) and Actinobacteria (26.70%). Tso Kar Lake sediment soil samples showed the most abundant phylum as Proteobacteria (46.28%). The study suggests that increased anthropogenic activity increases soil bacterial diversity. It may eventually help to develop new approaches for sustainable land-use management practices.
- 19 September 2024
- Published by ANSF Publications in Journal of Applied and Natural Science
- Vol. 16 (3) , 987-997
Open AccessComparative metagenomic analysis of bacterial diversity in three distantly related soils in India
Soil microbial diversity is a vital factor for the progression of vegetation and biogeochemical cycles in an ecosystem. It is affected by the chemical composition, soil microenvironment and anthropogenic activities. The present study investigated the effect of environmental conditions and anthropogenic activities on the bacterial diversity of three distantly related soils in India. The multiple soil samples were collected from Hospital waste sites (BTC2) with extensive anthropogenic activity, Himalayan forest soil (RM1) with low anthropogenic activity and Tso Kar Lake sediment soil samples with negligible anthropogenic activity with environmental factors such as soil pH, temperature and altitude on the bacterial diversity. The soil samples were analyzed for physico-chemical properties that suggest significant variations in pH, electrical conductivity (EC), total dissolved solids (TDS), temperature and altitude. The SEM-EDS (Scanning electron microscopy with energy-dispersive X-ray spectroscopy) analysis revealed the elemental composition of the soil samples. The bacterial diversity of three different soil samples was studied using 16S rRNA sequencing-based metagenomic analysis. The results suggested that the bacterial diversity in Hospital waste site soil samples was higher than in the other two soil samples based on chao1 (richness and evenness) analysis. The Phyla Firmicutes were more abundant in Hospital waste site soil, and Himalayan forest soil showed a higher abundance of phylum Proteobacteria (28.86%) and Actinobacteria (26.70%). Tso Kar Lake sediment soil samples showed the most abundant phylum as Proteobacteria (46.28%). The study suggests that increased anthropogenic activity increases soil bacterial diversity. It may eventually help to develop new approaches for sustainable land-use management practices.
- Open Access
- 27 May 2024
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 18 (2) , 1196-1208
Lichenysin Produced by Bacillus licheniformis RG1002 Inhibit the Biofilm Formation of Pseudomonas aeruginosa on Various Surfaces
Pseudomonas aeruginosa is capable of producing biofilms on various surfaces, medical implants and burn wounds which inhibit the action of antimicrobial agents. This study was undertaken for the screening, identification and purification of a natural antimicrobial compound from the hospital waste sites against P. aeruginosa. The partial purification of the antimicrobial agent was performed with ethyl acetate from the culture supernatant of the isolate and further purified by HPLC. For the characterization of the active compound, we have used Fourier Transform Infrared Spectroscopy (FT-IR) and Electrospray Ionization mass spectrometry (ESI-MS) analysis. The purified compound was tested for anti-biofilm activity in vitro against P. aeruginosa and on various surfaces such as plastic, glass, and steel. The potent isolate was confirmed as Bacillus licheniformis strain RG1002. The HPLC purified compound was characterized as lichenysin using FTIR and ESI-MS analysis. This study identifies and characterize the potent antimicrobial agent against other important human pathogens such as Staphylococcus aureus, Salmonella typhi, Shigella flexneri and Escherichia coli. Purified lichenysin showed strong inhibitory effect against P. aeruginosa and other important pathogens and inhibits the biofilm formation of P. aeruginosa in vitro on various types of surfaces. The current study suggests the application of lichenysin as a protective coating on various indwelling medical devices and catheters to prevent the biofilm formation by P. aeruginosa.
- 27 May 2024
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 18 (2) , 1196-1208
Open AccessLichenysin Produced by Bacillus licheniformis RG1002 Inhibit the Biofilm Formation of Pseudomonas aeruginosa on Various Surfaces
Pseudomonas aeruginosa is capable of producing biofilms on various surfaces, medical implants and burn wounds which inhibit the action of antimicrobial agents. This study was undertaken for the screening, identification and purification of a natural antimicrobial compound from the hospital waste sites against P. aeruginosa. The partial purification of the antimicrobial agent was performed with ethyl acetate from the culture supernatant of the isolate and further purified by HPLC. For the characterization of the active compound, we have used Fourier Transform Infrared Spectroscopy (FT-IR) and Electrospray Ionization mass spectrometry (ESI-MS) analysis. The purified compound was tested for anti-biofilm activity in vitro against P. aeruginosa and on various surfaces such as plastic, glass, and steel. The potent isolate was confirmed as Bacillus licheniformis strain RG1002. The HPLC purified compound was characterized as lichenysin using FTIR and ESI-MS analysis. This study identifies and characterize the potent antimicrobial agent against other important human pathogens such as Staphylococcus aureus, Salmonella typhi, Shigella flexneri and Escherichia coli. Purified lichenysin showed strong inhibitory effect against P. aeruginosa and other important pathogens and inhibits the biofilm formation of P. aeruginosa in vitro on various types of surfaces. The current study suggests the application of lichenysin as a protective coating on various indwelling medical devices and catheters to prevent the biofilm formation by P. aeruginosa.
- 1 August 2023
- Published by Springer Nature in Environment, Development and Sustainability
- Vol. 26 (9) , 21985-22011
Comprehensive study of microbial bioplastic: present status and future perspectives for sustainable development
- 1 August 2023
- Published by Springer Nature in Environment, Development and Sustainability
- Vol. 26 (9) , 21985-22011
Comprehensive study of microbial bioplastic: present status and future perspectives for sustainable development
- 16 July 2023
- Published by Elsevier in Microbial Pathogenesis
- Vol. 182, 106256
Emycin-E purified from Streptomyces sp. RG1011 from Himalayan soil has antibiofilm activity against Staphylococcus aureus
- 16 July 2023
- Published by Elsevier in Microbial Pathogenesis
- Vol. 182, 106256
Emycin-E purified from Streptomyces sp. RG1011 from Himalayan soil has antibiofilm activity against Staphylococcus aureus
- 14 November 2022
- Published by Taylor & Francis
- p. 177-189
Role and Application of CRISPR-Cas System in Genetic Disorders
CRISPR-Cas system has a potential role in diverse scientific fields such as agriculture, environment, and human health affected by familial or non-familial diseases. Interestingly, the absence of CRISP-Cas system in eukaryotes makes it a powerful tool for gene manipulation and editing in humans. Due to its low cost, easy manipulation, and straightforward mechanism, researchers find CRISPR-Cas systems the most advanced tool for gene therapeutics. Several clinical trials for the cure of human genetic disorders using CRISPR-Cas system are completed or underway. There are, however, some challenges with this technology, such as delivery of foreign DNA in the human body, host immune response, and risk of off-target mutations. However, we are very hopeful that in the near future scientists all over the world will find solutions for these hindrances and we can easily cure human genetic disorders. In this chapter we systematically explain the origin, mechanism of action, and application of CRISPR-Cas in human genetic disorders. The chapter will be very helpful for young researchers and students working in the field of gene therapeutics.
- 14 November 2022
- Published by Taylor & Francis
- p. 177-189
Role and Application of CRISPR-Cas System in Genetic Disorders
CRISPR-Cas system has a potential role in diverse scientific fields such as agriculture, environment, and human health affected by familial or non-familial diseases. Interestingly, the absence of CRISP-Cas system in eukaryotes makes it a powerful tool for gene manipulation and editing in humans. Due to its low cost, easy manipulation, and straightforward mechanism, researchers find CRISPR-Cas systems the most advanced tool for gene therapeutics. Several clinical trials for the cure of human genetic disorders using CRISPR-Cas system are completed or underway. There are, however, some challenges with this technology, such as delivery of foreign DNA in the human body, host immune response, and risk of off-target mutations. However, we are very hopeful that in the near future scientists all over the world will find solutions for these hindrances and we can easily cure human genetic disorders. In this chapter we systematically explain the origin, mechanism of action, and application of CRISPR-Cas in human genetic disorders. The chapter will be very helpful for young researchers and students working in the field of gene therapeutics.
- Open Access
- 23 November 2021
- Published by MDPI AG in Preprints.org
Multifunctional Biomimetic Nanofibrous Scaffold Loaded With Asiaticoside for Rapid Diabetic Wound Healing
The diabetic wound is one of the significant intricacies of having no standard treatment. Nanofibers are the arising and adaptable medication conveyance framework having unique properties for wound healing. The aim of this research is to prepare multifunctional biomimetic nanofibrous scaffold loaded with asiaticoside nanofibers for diabetic wound healing since it initiates the development of the extracellular matrix. It is made by mixing silk fibroin with polymers and loaded with asiaticoside using electrospinning. The in-vitro characterization, antimicrobial studies, cell-line studies and in-vivo wound healing studies were carried out. In vitro release shows sustained release behaviour of asiaticoside over an extended period of time due to crosslinking. SEM images verified diameter varied in the range between 100-200 nm and their tensile test strength upto 20 MP. In-vitro cytotoxicity shows less cytotoxicity of formulations and better cell migration. Antimicrobial studies show the efficacy of formulations against few species of bacteria. The in vivo study demonstrated a better wound healing effect in diabetic mice. In addition, the histopathological studies showed its ability to restore the normal structure of the skin and the histological condition of the tissues. The results suggest that silk fibroin-based asiaticoside nanofibers have great potential for diabetic wound healing applications.
- 23 November 2021
- Published by MDPI AG in Preprints.org
Open AccessMultifunctional Biomimetic Nanofibrous Scaffold Loaded With Asiaticoside for Rapid Diabetic Wound Healing
The diabetic wound is one of the significant intricacies of having no standard treatment. Nanofibers are the arising and adaptable medication conveyance framework having unique properties for wound healing. The aim of this research is to prepare multifunctional biomimetic nanofibrous scaffold loaded with asiaticoside nanofibers for diabetic wound healing since it initiates the development of the extracellular matrix. It is made by mixing silk fibroin with polymers and loaded with asiaticoside using electrospinning. The in-vitro characterization, antimicrobial studies, cell-line studies and in-vivo wound healing studies were carried out. In vitro release shows sustained release behaviour of asiaticoside over an extended period of time due to crosslinking. SEM images verified diameter varied in the range between 100-200 nm and their tensile test strength upto 20 MP. In-vitro cytotoxicity shows less cytotoxicity of formulations and better cell migration. Antimicrobial studies show the efficacy of formulations against few species of bacteria. The in vivo study demonstrated a better wound healing effect in diabetic mice. In addition, the histopathological studies showed its ability to restore the normal structure of the skin and the histological condition of the tissues. The results suggest that silk fibroin-based asiaticoside nanofibers have great potential for diabetic wound healing applications.
- Open Access
- 30 September 2020
- Published by Herald Scholarly Open Access in Advances in Microbiology Research
- Vol. 4 (1) , 1-7
Role And Application Of Curcumin As An Alternative Therapeutic Agent
The golden spice, turmeric has been an essential element in Asian culinary since many years. Curcumin is the major and important constituent of turmeric obtained from Curcuma longa L. Due to poor stability, solubility and biodegradability the effective concentration of curcumin was not able to reach to the tissues by oral consumption of turmeric in food. However, recent developments in drug delivery methods have elevated the formation of several nano-capsulation of curcumin. The formation of biodegradable nano-curcumin is one of the major breakthroughs for its therapeutic translation in humans and animals against various diseases. Since, ancient time it has been used for various ailments and also as a supportive therapeutic agent. Curcumin is now well-established therapeutic agent against cancer, neurodegenerative diseases, microbial infections, arthritis and other inflammatory disorders. It has hepatoprotective, immune-enhancer, cardiovascular and gastrointestinal effects. In this mini review article, we have explored the therapeutic role and application of curcumin in human diseases specifically as anti-bacterial and anti-cancer. The combinatorial study of curcumin with available drugs on different types of cancer has been discussed. We have also reviewed the types of nano-formulations available till date for curcumin and its role as therapeutic agent.
- 30 September 2020
- Published by Herald Scholarly Open Access in Advances in Microbiology Research
- Vol. 4 (1) , 1-7
Open AccessRole And Application Of Curcumin As An Alternative Therapeutic Agent
The golden spice, turmeric has been an essential element in Asian culinary since many years. Curcumin is the major and important constituent of turmeric obtained from Curcuma longa L. Due to poor stability, solubility and biodegradability the effective concentration of curcumin was not able to reach to the tissues by oral consumption of turmeric in food. However, recent developments in drug delivery methods have elevated the formation of several nano-capsulation of curcumin. The formation of biodegradable nano-curcumin is one of the major breakthroughs for its therapeutic translation in humans and animals against various diseases. Since, ancient time it has been used for various ailments and also as a supportive therapeutic agent. Curcumin is now well-established therapeutic agent against cancer, neurodegenerative diseases, microbial infections, arthritis and other inflammatory disorders. It has hepatoprotective, immune-enhancer, cardiovascular and gastrointestinal effects. In this mini review article, we have explored the therapeutic role and application of curcumin in human diseases specifically as anti-bacterial and anti-cancer. The combinatorial study of curcumin with available drugs on different types of cancer has been discussed. We have also reviewed the types of nano-formulations available till date for curcumin and its role as therapeutic agent.